3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Cyclosporine
5
Cyclophosphamide
5
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Mycophenolic Acid
3
thymoglobulin
2
Methotrexate
2
Antilymphocyte Serum
2
venetoclax
1
trihexyltetradecylphosphonium chloride
1
treosulfan
1
tocilizumab
1
Whole-Body Irradiation
1
Thiotepa
1
Tacrolimus
1
Sirolimus
1
Semustine
1
Rituximab
1
Radiotherapy
1
Polymerase Chain Reaction
1
Physical Therapy Modalities
1
Peripheral Blood Stem Cell Transplantation
1
Maraviroc
1
Interferon alpha-2
1
Immunoenzyme Techniques
1
Drug Therapy
1
Decitabine
1
Cytarabine
1
Cyclosporins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Graft vs Host Disease
×
trihexyltetradecylphosphonium chloride
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled